Recent clinical experience has shown that people with diabetes are at higher risk of death from COVID19 and that COVID-19 drives an increased risk of hyperglycemia and other complications in those with and without diabetes. This is in addition to the risk due to advanced age and chronic disease. Both the biological mechanisms underlying this risk and how to minimize it remain poorly understood. There is an urgent need for research to understand the impact of diabetes on COVID-19 and vice versa. This is true at a basic and clinical level. 
 

The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH) are designed to provide funding to gather data related to IVF programmes during the COVID-19 pandemic including but not limited to:  

Follow-up data on infected pregnant patients at different gestational stages, including spontaneous pregnancies.  

This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic.

The COVID-19 Related Research Grants support education research projects that will contribute to understanding the rapid shifts in education in this time of crisis and change. We are especially interested in supporting two primary categories of projects. First, we are interested in supporting studies that aim to understand and disrupt the reproduction and deepening of educational inequality caused by the COVID-19 crisis. Second, we also recognize that in times of great disruption and change, there may be opportunities to remake and imagine anew forms of equitable education.

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that leverages the National Institutes of Health (NIH) Point-of-Care Technology Research Network (POCTRN).

While tremendous progress has been made in advancing CPS technologies, the demand for innovation across application domains is driving the need to accelerate fundamental research to keep pace. At the same time, the CPS program seeks to open new vistas for the research community to think beyond the usual cyber-physical paradigms and structures and propose creative ideas to address the myriad challenges of today's systems as well as those of the future that have not yet been designed or fielded.

We are now accepting letters of inquiry for the 2020-2021 funding cycle of NIHCM Foundation's investigator-initiated research grant program.

This funding opportunity seeks to support effective coalitions that will bolster and leverage U.S.-India collaboration across a range of fields to fight COVID-19, in India and globally. Potential grantees should be able to implement a small-grants program to promote innovation in addressing COVID-19, encourage partnerships between U.S.

The Emergency Medicine Foundation invites applications for its COVID-19 research grant. This supports research that will provide high-impact new knowledge to advance emergency patient care, improve response of hospitals, healthcare and emergency medical services systems, and protect emergency medicine healthcare professionals during pandemics. Topics may include the following areas:

- personal protective equipment, including design, cleaning and reuse;
- ventilator scarcity;
- telemedicine;
- laboratory testing;

This program supports projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/comparative clinical effectiveness research (PCOR/CER) enterprise, aiming to help communities increase their capacity to participate across all phases of the PCOR/CER process while responding to contextual changes as a result of the COVID-19 pandemic.